Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Vikas Garg; Amit M. Oza

doi:10.1158/1078-0432.CCR-24-3905

Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?

Vikas Garg & Amit M. Oza

Summary

Endocrine therapy (ET) has been underexplored in endometrial cancer. Emerging data suggest that combining ET with cyclin-dependent kinase 4/6 inhibitors improves outcomes in endometrial cancer. This commentary complements a recent CCR article and reviews the opportunities to improve precision ET and the potential to overcome resistance mechanisms associated with ET failure.

See related article by Green et al., p. 2088

Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?

Summary

Links

Journal

Institutions

Authors